DOI QR코드

DOI QR Code

Association between coronavirus disease 2019-related workplace interventions and prevalence of depression and anxiety

  • Hyun Woo Park (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Seung Hyun Park (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Young Wook Kim (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • JunSeok Son (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Chan Woo Kim (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Hyoung Ouk Park (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Jun Ho Lee (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Young Hoo Shin (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Chang Ho Chae (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Eui Yup Chung (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Hun Jeong (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
  • Received : 2022.03.22
  • Accepted : 2022.05.17
  • Published : 2022.12.31

Abstract

Background: Although coronavirus disease 2019 is causing a variety of psychological problems for workers, there are few longitudinal studies on changes in workers' mental health by workplace intervention. This study aimed to evaluate the change in the prevalence of depression and anxiety according to the active involvement of the workplace. Methods: This study was conducted on 1,978 workers at a workplace who underwent a health screening from January 2019 to August 2020, and classified depression and anxiety disorders using a self-report questionnaire. After the first pandemic, the company stopped health screening, took paid leave and telecommuting, and conducted interventions such as operating its own screening clinic. To see if this workplace intervention affects workers' mental health, we conducted generalized estimating equations to compare odds ratio (OR). Results: In the pre-intervention group, 384 people (16.86%) had depression, and 507 people (22.26%) had anxiety disorder. Based on the OR before intervention, the OR of depression decreased to 0.76 (0.66-0.87) and the OR of anxiety disorder decreased to 0.73 (0.65-0.82). Conclusions: As a result of this study, it was confirmed that workplace intervention was related to a decrease in depression and anxiety. This study provides basic data to improve workers' mental health according to workplace intervention, and further research is needed according to workplace intervention in the future.

Keywords

Acknowledgement

The authors would like to thank Jae Chul Ha for technical assistance for this study.

References

  1. Holmes EA, O'Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 2020;7(6):547-60. https://doi.org/10.1016/S2215-0366(20)30168-1
  2. Santomauro DF, Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021;398(10312):1700-12. https://doi.org/10.1016/S0140-6736(21)02143-7
  3. Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 2020;417:117085.
  4. Ma L, Song JN, Song YP, Zhao LT, Chen H. Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: a protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99(50):e23293.
  5. Qian Y, Xu H, Diao J, Li Q, Zhan Q, Fang Y. Influence of life intervention on anxiety, depression, and quality of life of COVID-19 patients: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100(18):e25391.
  6. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020;395(10227):912-20. https://doi.org/10.1016/S0140-6736(20)30460-8
  7. Gruber J, Prinstein MJ, Clark LA, Rottenberg J, Abramowitz JS, Albano AM, et al. Mental health and clinical psychological science in the time of COVID-19: Challenges, opportunities, and a call to action. Am Psychol 2021;76(3):409-26. https://doi.org/10.1037/amp0000707
  8. Lepine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat 2011;7 Suppl 1:3-7. https://doi.org/10.2147/NDT.S19617
  9. Bowman D, Scogin F, Lyrene B. The efficacy of self-examination therapy and cognitive bibliotherapy in the treatment of mild to moderate depression. Psychother Res 1995;5(2):131-40. https://doi.org/10.1080/10503309512331331256
  10. Proudfoot J, Ryden C, Everitt B, Shapiro DA, Goldberg D, Mann A, et al. Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 2004;185(1):46-54. https://doi.org/10.1192/bjp.185.1.46
  11. Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, et al. Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry 2005;162(6):1158-64. https://doi.org/10.1176/appi.ajp.162.6.1158
  12. Lovell K, Bower P, Richards D, Barkham M, Sibbald B, Roberts C, et al. Developing guided self-help for depression using the Medical Research Council complex interventions framework: a description of the modelling phase and results of an exploratory randomised controlled trial. BMC Psychiatry 2008;8(1):91.
  13. Williams C, Wilson P, Walker A, Wallace I, Morrison J, Whitfield G, et al. An evaluation of the Effectiveness of Structured Cognitive Behaviour Therapy Self-Help Materials Delivered by a Self-Help Support Worker Within Primary Care. Report Submitted to the Chief Scientific Officer in Scotland (contract number CZH/4/61). Glasgow, Scotland: University of Glasgow; 2007.
  14. Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry 2016;61(9):524-39. https://doi.org/10.1177/0706743716659418
  15. Culpepper L. Generalized anxiety disorder in primary care: emerging issues in management and treatment. J Clin Psychiatry 2002;63 Suppl 8:35-42.
  16. Shields GS, Spahr CM, Slavich GM. Psychosocial interventions and immune system function: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2020;77(10):1031-43. https://doi.org/10.1001/jamapsychiatry.2020.0431
  17. Niileksela CR, Ghosh A, Janis RA. Dynamic changes in generalized anxiety and depression during counseling. J Couns Psychol 2021;68(1):112-24. https://doi.org/10.1037/cou0000441
  18. Oakman J, Kinsman N, Stuckey R, Graham M, Weale V. A rapid review of mental and physical health effects of working at home: how do we optimise health? BMC Public Health 2020;20(1):1825.
  19. Kim D. Does paid vacation leave protect against depression among working Americans? A national longitudinal fixed effects analysis. Scand J Work Environ Health 2019;45(1):22-32. https://doi.org/10.5271/sjweh.3751
  20. Hwang S. Estimation of high-risk drinkers and drinking behavior in Korea-focusing on Korean National Health and Nutrition Examination Survey (KNHANES) and Korean Statistical Information Service data. J Environ Health Sci 2020;46(1):65-77.
  21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1(3):385-401. https://doi.org/10.1177/014662167700100306
  22. Jeon SW, Han C, Ko YH, Yoon S, Pae CU, Choi J, et al. A Korean validation study of the clinically useful anxiety outcome scale: comorbidity and differentiation of anxiety and depressive disorders. PLoS One 2017;12(6):e0179247.
  23. Wu S, Zhang K, Parks-Stamm EJ, Hu Z, Ji Y, Cui X. Increases in anxiety and depression during COVID-19: a large longitudinal study from China. Front Psychol 2021;12:706601.
  24. Fancourt D, Steptoe A, Bu F. Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study. Lancet Psychiatry 2021;8(2):141-9. https://doi.org/10.1016/S2215-0366(20)30482-X
  25. Waterman S, Hunter EC, Cole CL, Evans LJ, Greenberg N, Rubin GJ, et al. Training peers to treat Ebola centre workers with anxiety and depression in Sierra Leone. Int J Soc Psychiatry 2018;64(2):156-65. https://doi.org/10.1177/0020764017752021
  26. David D, Cristea I, Hofmann SG. Why cognitive behavioral therapy is the current gold standard of psychotherapy. Front Psychiatry 2018;9:4.
  27. Zhou L, Xie RH, Yang X, Zhang S, Li D, Zhang Y, et al. Feasibility and preliminary results of effectiveness of social media-based intervention on the psychological well-being of suspected COVID-19 cases during quarantine. Can J Psychiatry 2020;65(10):736-8. https://doi.org/10.1177/0706743720932041
  28. Schroder J, Berger T, Westermann S, Klein JP, Moritz S. Internet interventions for depression: new developments. Dialogues Clin Neurosci 2016;18(2):203-12. https://doi.org/10.31887/DCNS.2016.18.2/jschroeder